Mercados españoles cerrados

Edwards Lifesciences Corporation (EW)

NYSE - Nasdaq Precio en tiempo real. Divisa en USD
Añadir a la lista de favoritos
87,77+0,77 (+0,89%)
Al cierre: 04:00PM EDT
87,77 0,00 (0,00%)
Después del cierre: 05:16PM EDT

Edwards Lifesciences Corporation

One Edwards Way
Irvine, CA 92614
United States
949 250 2500
https://www.edwards.com

Sector(es)Healthcare
SectorMedical Devices
Empleados a tiempo completo19.800

Ejecutivos clave

NombreTítuloPagaEjecutadoAño de nacimiento
Mr. Bernard J. ZovighianCEO & Director2,27MN/A1968
Mr. Scott B. UllemCorporate VP & CFO1,35M6,36M1967
Mr. Donald E. Bobo Jr.Corporate Vice President of Strategy & Corporate Development1,27M2,68M1962
Mr. Larry L. WoodCorporate VP and Group President of TAVR & Surgical Structural Heart1,49M2,13M1966
Dr. Todd J. Brinton FACC, M.D.Corporate VP of Advanced Technology & Chief Scientific OfficerN/AN/AN/A
Mark WilterdingVice President of Investor RelationsN/AN/AN/A
Mr. Arnold A. PinkstonCorporate VP & General CounselN/AN/A1959
Mr. Dirksen J. LehmanCorporate Vice President of Public AffairsN/AN/AN/A
Ms. Christine Z. McCauleyCorporate Vice President of Human ResourcesN/AN/A1965
Mr. Gary I. SorsherSenior Vice President of Quality & Regulatory ComplianceN/AN/A1965
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Gobierno corporativo

El ISS Governance QualityScore de Edwards Lifesciences Corporation, a día 1 de junio de 2024, es 3. Las puntuaciones base son Auditoría: 5; Tablero: 3; Derechos de los accionistas: 3; Compensación: 4.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.